Hemoglobin subunit gamma-2 gene promoter (HBG2 promoter)

The **hemoglobin subunit gamma 2 gene promoter** is a DNA regulatory sequence located upstream of the HBG2 coding region. It controls the transcription and expression of the hemoglobin subunit gamma 2 protein, which is a component of fetal hemoglobin (HbF). The activity of this promoter determines when and how much HBG2 is expressed, particularly during fetal development in tissues such as liver, spleen, and bone marrow[2][5]. After birth, expression from this promoter typically decreases as adult forms of hemoglobin predominate. This target is not itself a protein or receptor but rather a **promoter DNA sequence**, so it does not fit standard categories like enzyme or receptor. However, it plays an important role in diseases such as sickle cell disease and beta-thalassemia because increased activity at this promoter can elevate HbF levels and ameliorate symptoms[5]. Some research focuses on modulating transcription factors that bind to this region to reactivate fetal hemoglobin production in adults[4]. There are no direct drugs targeting the DNA sequence itself; instead, therapeutic strategies may involve modifying its regulation via genome editing or small molecules that affect associated transcription factors. Thus, while biologically significant for therapy development, it is not considered a canonical drug target like proteins or receptors. **Note:** This entry refers specifically to a *gene regulatory element* rather than a protein-coding target. If you intended information about the encoded protein ("Hemoglobin subunit gamma 2"), see entries for "HBG2" or "gamma-globin"[1][3][5].

Other names

HBG2 promoterGamma-globin gene promoterHemoglobin gamma 2 gene regulatory region